Transgenic expression of SAG in mouse skin impairs tumor formation at early stages by targeting c-Jun/AP1 for degradation, whereas it promoted tumor growth at later stages by targeting IκBα to activate NF-κB [11]. The gene discussed is JUN; the disease is neoplasm.